Manika Lall is the associate director of public affairs at Gilead Sciences, where she is part of Gilead’s Corporate Citizen team. Lall directs the company’s grant-making to organizations working to expand access to health care services for HIV, viral hepatitis, and visceral Leishmaniasis in low- and middle-income countries. Prior to Gilead, Lall worked for another United States biotech company, bringing innovative solutions to link patients to care.